Rare diseases
Investigational molecules
Locations
Roervangsvej 30, 4300 Holbæk, Denmark
Pharmacosmos A/S supports clinical research in transfusion-dependent thalassemia, low-risk myelodysplastic syndromes, and related iron overload conditions, with interest in therapies that address chronic transfusion burden and iron accumulation.
The sponsor’s research activity also extends to agents intended for iron removal and management of haemolysis in transfusion-related disorders.
Pharmacosmos A/S runs clinical trials in conditions such as Cardiac failure chronic, Iron deficiency, Thalassaemia beta, Thalassaemia alpha, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
BulgariaStudy of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia
DenmarkA Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer
BelgiumStudy on Trilaciclib and Topotecan for Patients with Extensive Stage Small Cell Lung Cancer
AustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
